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Abstract
Background: Circulating epithelial progenitor cells are important for repair of the airway epithelium in a mouse model of
tracheal transplantation. We therefore hypothesized that circulating epithelial progenitor cells would also be present in
normal human subjects and could be important for repair of the airway after lung injury. As lung transplantation is
associated with lung injury, which is severe early on and exacerbated during episodes of infection and rejection, we
hypothesized that circulating epithelial progenitor cell levels could predict clinical outcome following lung transplantation.
Methodology/Principal Findings: Quantitative Real Time PCR was performed to determine peripheral blood mRNA levels of
cytokeratin 5, a previously characterized marker of circulating epithelial progenitor cells. Cytokeratin 5 levels were evaluated
in healthy human subjects, in lung transplant recipients immediately post-transplant and serially thereafter, and in heart
transplant recipients. All normal human subjects examined expressed cytokeratin 5 in their buffy coat in amounts that were
not significantly influenced by age or gender. There was a profound, statistically significant decrease in cytokeratin 5 mRNA
expression levels in lung transplant patients compared to healthy human subjects (p = 3.1610213) and to heart transplant
recipients. There was a moderate negative correlation between improved circulating cytokeratin 5 mRNA levels in lung
transplant recipients with recovering lung function, as measured by improved FEV1 values (rho =20.39).
Conclusions/Significance: Levels of cytokeratin 5 mRNA, a proxy marker for circulating epithelial progenitor cells, inversely
correlated with disease status in lung transplant recipients. It may therefore serve as a biomarker of the clinical outcome of
lung transplant patients and potentially other patients with airway injury.
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Introduction
The proximal airway epithelium is in contact with the
environment and, as such, is at constant jeopardy from
environmental injury. An efficient mechanism for airway repair
is therefore essential to protect the host. Our current understand-
ing of proximal airway repair is that a progenitor cell pool is
located in the submucosal glands and submucosal gland ducts that
are capable of self renewal and of differentiating in to the proximal
airway subtypes e.g. mucus and ciliated cells [1,2,3,4,5]. These
progenitor cells express the immature cytokeratins (CK) CK5 and
CK14 and move up the submucosal gland ducts to form the basal
layer of the pseudostratified columnar epithelium of the proximal
airway. From there the basal cells lose CK5/14 and gain more
mature cytokeratins e.g. CK8/18 as they differentiate and move
apically.
We have shown the presence of circulating CK5 expressing cells
that contributed to airway repair in a mouse model of ischemic
injury and proximal airway repair [6]. We used FACS analysis to
show the presence of CK5 expressing cells in the bone marrow
and circulation of mice [6]. The identification of circulating
epithelial cells that contribute to airway repair represents a
controversial paradigm shift in the current concept of airway
repair and regeneration after injury. The overall aims of this study
were to determine whether CK5 mRNA expression could be
quantified in the circulation of normal human subjects and to
determine whether CK5 mRNA levels would be altered with
severe airway disease, such as in lung transplant patients with end
stage lung disease. We also hypothesized that CK5 mRNA
expression levels would increase as patients recovered post lung
transplant and could function as a clinical biomarker of airway
disease.
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Results
Detection of CK5 in the Circulation of Normal Human
Subjects and Patients by Conventional PCR
We performed conventional PCR on cDNA obtained from the
blood of normal human subjects and detected message for CK5 in
all normal human subjects examined. PCR on lung transplant
patient cDNA samples from the buffy coat revealed the presence
of mRNA for CK5 in only some of the lung transplant patients.
PCR with GAPDH primers was used to confirm the integrity of
the cDNA (Figure 1A).
Validation of the Quantitative Real Time PCR Assay for
CK5
The multiplex Quantitative Real Time PCR assay was first
performed with varying concentrations of primer and then probe
to determine the optimal concentration of primers and probe for
the assay (Table 1). The concentration at which, for both primers
and probe, the DCt and DRn did not change with increasing
concentrations was selected. Thus primer concentrations of
600 nm and probe concentration of 250 nm were chosen. Then
a standard curve consisting of serial dilutions of cDNA was
performed with the determined CK5 primer and probe concen-
trations to determine the linear range of the assay. The triplicate
reproducibility was noted to start to fall off the curve at threshold
cycle (Ct) values greater than 36 (Figure 1Bi). The linear range of
the GAPDH assay is more extensive than the CK5 assay because
of the abundance of GAPDH expression (Figure 1Bii).
Quantification of the CK5 mRNA in Normal Human
Subjects
The triplicate Ct values for each sample were averaged resulting
in mean Ct values for both CK5 and GAPDH. The CK5 Ct
values were then standardized to the housekeeping gene by taking
the difference: DCt=Ct[CK5]2Ct[GAPDH]. Most of the CK5
quantitative real-time PCR data were analyzed using the DCt
variable, as it was approximately normally distributed in some sub
groups of data. Kendall rank correlation was used to test for a DCt
relationship with age in the control samples and an exact
Wilcoxon rank sum test was used to compare DCt distributions
between male and female control samples. Both tests yielded non-
significant results (p-value = 0.24 and 0.93, respectively). A
Figure 1. A. PCR for CK5 mRNA from the circulation of healthy volunteers and lung transplant patients. The top panel shows the expected 439 bp
fragment for CK5 using cDNA as template in healthy volunteers (Lanes 1–4) and CK5 mRNA expression from a representative group of patients post
lung transplantation (Lanes 5–9). CK5 mRNA expression was not found in PCR Lanes 5, 8 and 9 and neither was CK5 mRNA expression detectible by
quantitative real-time PCR in these samples. Lane 10 represents the positive control, which consists of a bacterial artificial chromosome (BAC)
containing 170 kb of genomic sequence surrounding the CK5 locus as template, which is why the band is a larger size. Lane 11 is the negative control
without cDNA template. The bottom panel shows PCR amplification of GAPDH from the same templates. B. Standard curve of real-time PCR
amplification of CK5 and GAPDH. The log quantity of RNA is plotted against the mean threshold cycle (Ct), measured in triplicate. Slope and intercept
are represented in the equations of the regression lines, along with the regression coefficient.
doi:10.1371/journal.pone.0005925.g001
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scatterplot of DCt vs. log of age is shown in Figure 2A. A boxplot
of the sex-specific DCt values shows that there was no significant
difference between males and females in our control data
(Figure 2B).
Longitudinal study of CK5 mRNA in Lung Transplant
Patients
We followed CK5 levels in a cohort of 23 lung transplant
patients, ranging in age from 31–79 years that received transplants
at the David Geffen School of Medicine at UCLA between
February 2006 and March 2007. All patients had end stage lung
disease at the time of transplant. About 30% of patients were
transplanted for chronic obstructive pulmonary disease (COPD),
about 30% for idiopathic pulmonary fibrosis (IPF) and the
remaining for a variety of diagnoses. Most patients had 2–4
appointments within the year following their transplant where
blood samples were drawn and their pulmonary function was
tested. Table 2 details the lung transplant patient demographics.
We found a 75-fold decrease in CK5 mRNA expression in the
cohort of lung transplant patient samples tested post-transplant in
comparison to healthy control subjects with 95% CI (33.36, 204.9)
and p-value of 3.1610213 by the Wilcoxon rank sum test. This
result is highly significant even after correcting for the multiple
Table 1. Optimization of the Assay for Primers and Probes.
[Primers (ea)] (nM) [Probe] (nM) Mean CK5 Ct CK5 Ct SE Mean GAPDH Ct
50 250 37.414 1.073 21.894
100 250 31.479 0.282 21.851
200 250 27.62 0.151 21.846
400 250 26.294 0.098 21.754
600 250 26.224 0.175 21.62
900 250 25.955 0.139 21.623
[Primers (ea)] (nM) [Probe] (nM) Mean CK5 Ct CK5 Ct SE Mean GAPDH Ct
600 50 30.085 0.139 21.651
600 100 29.278 0.078 21.752
600 150 28.815 0.083 21.825
600 200 28.59 0.71 21.9
600 250 28.405 0.023 21.97
The Quantitative Real Time PCR assay was first performed with varying concentrations of primer and then probe to determine the optimal concentration of primers and
probe for the assay. The concentration at which, for both primers and probe, the DCt and DRn did not change with increasing concentrations was selected. Thus primer
concentrations of 600 nM and probe concentration of 250 nM were chosen.
doi:10.1371/journal.pone.0005925.t001
Figure 2. A. Quantitative real-time PCR of CK5 plotted against age of normal human subjects. A scatter plot of data shows no significant difference
between the log of the age and CK5 mRNA expression levels in all 38 normal human subjects examined (p= 0.273). B. Quantitative real-time PCR
expression of CK5 does not differ with gender. A box plot demonstrates the similarity in CK5 levels in male and female normal human subjects (p= 0.84).
doi:10.1371/journal.pone.0005925.g002
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testing per patient, which would conservatively suggest a 0.005
significance level (for approximately 10 tests). Figure 3 shows a
boxplot comparison of DCt values between cases and controls.
All patients in the cohort were alive at more than one year post
transplant, and to date none have developed bronchiolitis
obliterans. No correlation in CK5 expression was found in
patients with episodes of rejection or infection, although the study
is not sufficiently powered to address this question. No significant
difference in CK5 expression was found between patients with
COPD compared to other airway diseases post-lung transplanta-
tion (p-value = 0.106). There was also no significant difference
between single and double lung transplant recipients. However,
only 5 of the 23 patients received a single lung transplant.
We then examined patient outcomes by correlating their CK5
levels with time post-transplantation. CK5 mRNA expression was
found to increase from the immediate post transplant period
(within the first week when the donor graft has significant ischemic
and reperfusion injury), to the latest available time point (typically
3–6 months post transplant) with a 9.2 fold increase in CK5
expression from the first CK5 level measured post-transplant to
the last CK5 level post-transplant with 95% CI (2.42, 40.6) and a
p-value of 1.461025 for the correlation of CK5 mRNA expression
and time post-transplant (Figure 4A). As expected, we also found a
highly significant correlation between improvement in FEV1 and
time post-transplantation (p-value = 4.761025) (Figure 4B). There
is a moderate negative correlation between average FEV1 and
average DCt values per patient of 20.39. However, this did not
reach statistical significance with a p-value = 0.085 (Figure 4C).
In order to determine whether the reduction in circulating CK5
expression was specific to lung transplant patients, we examined
CK5 expression in the circulation of heart transplant patients. We
found a significant difference between the CK5 expression levels in
heart transplant compared to lung transplant patients, with the
heart transplant patients having levels of CK5 expression in the
circulation that were significantly greater than the lung transplant
patients (p-value = 0.004). There was an approximately 20.6 fold
decrease in CK5 mRNA expression in lung transplant patients as
compared to heart transplant patients (95% CI: 4.24, 191)
(Figure 3). However, there was a trend for heart transplant
patients to express less CK5 in circulation than normal human
subjects (p-value = 0.05).
Discussion
Building on our previous studies on CK5 expressing circulating
epithelial progenitor cells in the circulation, our present findings
demonstrate the presence of CK5-positive cells in circulation in
normal human subjects[6]. Furthermore, they correlate the levels
of CK5 in circulation with lung status post transplant. The
significant reduction in CK5 expressing cells in the circulation of
lung transplant patients argues that there may be a role for
circulating epithelial progenitor cells in normal airway repair. This
is further emphasized by the correlation that was found between
an increase in circulating epithelial progenitor cells and an
improvement in lung function after transplantation. Together,
these results are consistent with the view that circulating epithelial
progenitor cells may be critical for normal airway repair and that a
lack of circulating epithelial progenitor cells may be associated
with airway disease.
One limitation of the patient studies is the inability to determine
the origin of the circulating epithelial progenitor cells. Our results
suggest that the origin of CK5 expressing cells in circulation may
be from the bone marrow, the thymus, or may be derived from the
lung tissue itself, or may be derived from all of these
compartments. If the origin of the circulating epithelial progenitor
cells is the bone marrow then it is possible that the immunosup-
pression that the lung transplant patients are on could be
responsible for the decrease in the expression of CK5. We
therefore analyzed the expression of CK5 in the circulation of
heart transplant patients who are also on immunosuppression but
do not have any major airway epithelial injury. We found a
significant difference between the amount of circulating epithelial
progenitor cells in heart transplant patients and lung transplant
patients, which suggests that circulating epithelial progenitor cells
are specific for airway repair. We also found a trend towards heart
transplant patients having less circulating epithelial progenitor cells
than normal human subjects. The heart transplant group were on
lower doses of immunosuppression than the lung transplant
patients, which suggests that immunosuppression may be playing a
role in the reduction of circulating epithelial progenitor cells found
in transplant patients. It is also possible that the differences in CK5
expression in circulation may result from changes in vascular
permeability or altered blood supply to the lung allografts.
We did not find a difference in CK5 mRNA expression in
normal human subjects with increasing age and this might be
expected as normal repair and regeneration decreases with age.
However, there are likely many variables in addition to age that
contribute to overall repair of the airway. CK5 expressing cells are
also found as basal cells in other complicated epithelia, most
notably skin and prostate. We would therefore have predicted that
Table 2. Lung transplant patient demographics.
Patient # Age (yr) Gender Diagnosis
Single/Double
Lung
1 58 M COPD Double
2 58 M COPD Double
3 64 F COPD Double
4 62 M PCH Double
5 61 M COPD Double
6 47 F sarcoid Double
7 60 F COPD Double
8 57 M IPF Double
9 31 M scleroderma Double
10 45 F PHTN Double
11 59 M IPF Double
12 63 F COPD Single
13 55 F ILD Double
14 60 M PHTN Double
15 53 M ILD Double
16 63 F IPF Single
17 55 F COPD Double
18 66 F COPD Single
19 56 F IPF Double
20 33 M scleroderma Double
21 79 M IPF Single
22 70 M IPF Single
23 62 M IPF Double
COPD= chronic obstructive pulmonary disease; IPF = idiopathic pulmonary
fibrosis; PHTN=pulmonary hypertension; ILD = interstitial lung disease;
PCH= Pulmonary capillary hemangiomatosis.
doi:10.1371/journal.pone.0005925.t002
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gender differences might be seen, although this was not the case in
our control samples. However, as benign prostatic hypertrophy is
associated with advancing age, it will be important in the future to
examine CK5 levels in older normal human subjects to determine
if there is a gender difference in this group.
Previous studies on the engraftment of bone marrow-derived
epithelial cells in the distal airway after lung injury have shown
conflicting results [7,8,9,10,11,12]. Our results demonstrated that
circulating epithelial cells are present in the circulation of all
normal human subjects examined. However, flow cytometry
analysis of CK5 expressing cells in circulation are required to
confirm this. Our experiments were performed retrospectively on
frozen RNA samples and therefore flow cytometry for CK5 could
not be performed. Our studies were not designed to assess the
magnitude of engraftment of the circulating epithelial cells in the
airway. However, the statistically significant difference between
lung transplant patients and normal human subjects with regard to
their CK5 mRNA levels suggested that circulating epithelial cells
may be important in normal airway repair. In addition, the
correlation of the increase in CK5 levels with the improvement in
pulmonary function testing post-transplantation suggests that CK5
mRNA levels in circulation could be used as a biomarker of airway
repair. By implication, it would appear that circulating epithelial
progenitor cells most likely do play an important role in airway
repair, although whether this is a direct of indirect effect still needs
to be established. Ultimately, determining whether CK5 mRNA
levels can be linked to the development of either acute or chronic
rejection and/or infection is critical and is an area of active
investigation in the lab.
In summary, CK5 expressing circulating epithelial progenitor
cells are present in circulation in normal human subjects and can
be quantified with the real time PCR assay that we have
established. Furthermore, the circulating epithelial progenitor
cells are significantly reduced immediately after lung transplanta-
tion, and then increase with time as lung function improves. We
suggest that circulating epithelial progenitor cells may play an
important role in airway repair after lung transplantation. In
addition, circulating epithelial progenitor cells may be used as a
biomarker of airway repair.
Methods
Selection and description of participants
Ethics statement. The research was approved by the UCLA
Institutional Review Board (IRB). IRB approval and informed
written consent were obtained from all patients and normal
human subjects examined. Data were analyzed anonymously.
Patients that were part of this study were patients at the
University of California Los Angeles, and received lung transplants
between 2005 and 2006. The patients in the study were placed on
standard pre- and post-lung transplant immunosuppression and
antimicrobials, as per standard of care. Only patients $ 18 years
of age were included, as there is no pediatric lung transplant
program at UCLA, otherwise all lung transplant recipients at
UCLA were included.
Exclusion criteria included individuals involved in a clinical
research trial utilizing an investigational therapy, pregnant
women, lactating women, or women of childbearing age not
willing to take precautions to avoid becoming pregnant during the
study.
Subjects underwent peripheral blood collection just prior to
lung transplantation. At 24 hours post lung transplant all
recipients had their peripheral blood collected and then underwent
a bronchoscopy with transbronchial biopsy. In addition, both
peripheral blood and bronchoscopy with transbronchial biopsy
were performed at 1week, 4 weeks, 3 months and 6 months post-
transplantation and also when clinically indicated to evaluate for
infection and/or rejection. We reported FEV1 as a percentage of
Figure 3. Quantitative real-time PCR of CK5 expression in normal human subjects compared to lung transplant patients and heart
transplant patients. A box plot demonstrates the differences between CK5 values in normal human subjects compared to lung transplant patients
(p = 3.1610213). A further comparison is made between CK5 mRNA expression in the circulation of heart transplant patients (n = 6) and lung
transplant patients (p = 0.004).
doi:10.1371/journal.pone.0005925.g003
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the patient’s best FEV1 post-transplant. Therefore, 100% FEV1 is
the best FEV1 measurement obtained for a particular patient. The
best FEV1 measurement typically occurred after the first 6 months
post-transplant.
Blood samples
Venous blood samples were obtained from 23 lung transplant
patients (aged 31–79 years) and 28 healthy volunteers (aged 19–54
years). 3 of the healthy volunteers smoked on a daily basis. None of
the healthy volunteers reported any health problems. Blood
samples were drawn from 6 heart transplant patients. All samples
were collected in EDTA containing tubes. In the volunteer group,
two 5 ml samples were collected and the first was discarded. This
step was performed to eliminate possible contamination with
epithelial cells from the epidermis during venipuncture. In the
heart transplant group, samples were collected from central
venous catheters. Not all of the patients had all time points
measured, but 65% of the patients had at least 4 measurements
and 17% of the patients had 1–2 measurements. We had only 3
patients with a pre-transplant measurement.
RNA extraction and cDNA synthesis
Lung Transplant Patients. Total RNA was isolated from
buffy coat. Initially, buffy coat was collected from fresh whole
blood following a 10 minute spin at 4506 g. One (1) ml TRIzol
Reagent (Invitrogen, Carlsbad, CA) and 0.2 volume chloroform
was added per 56106 cells and the lysates were centrifuged at
12,0006 g. RNA was collected in the aqueous phase. The RNA
was then precipitated in isopropanol and washed with 70%
ethanol. The resulting pellet was resuspended in 100 ml nuclease
free water and further purified using the RNeasy Mini Kit
(Qiagen, Valencia, CA) with on-column DNA digestion using the
RNase-free DNase kit (Qiagen) as per the manufacturer’s
instructions.
Volunteers and Heart Transplant Patients. Total RNA
was extracted from a 1.5 ml aliquot of fresh whole blood using the
Figure 4. A. Quantitative real-time PCR of CK5 expression in lung transplant patients correlated with time post-transplant. This box plot shows the
increase in CK5 mRNA expression (decrease in DCt for CK5) with time post transplant. The X-axis represents set time points post transplant (0 = time
of transplant; 1 = 1day post-transplant (PT); 2 = 1week PT; 3 = 1month PT; 4 = 3months PT; 5 = 6months PT). B. Percentage decrease in FEV1 in lung
transplant patients correlated with time post-transplant. Box plot of FEV1 on the Y-axis with 0.0 being 100% FEV1 compared to time post transplant
on the X-axis (0 = time of transplant; 1 = 1day PT; 2 = 1week PT; 3 = 1month PT; 4 = 3months PT; 5 = 6months PT). C. Quantitative real-time PCR of CK5
expression in lung transplant patients correlated with percentage decrease in FEV1 post-transplant. There is a moderate negative correlation
between average FEV1 and average DCt values of 20.39. However, this does not reach statistical significance with a p-value= 0.085.
doi:10.1371/journal.pone.0005925.g004
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RNeasy Blood Mini Kit (Qiagen). Manufacturer’s instructions
were followed except that following lysis of red blood cells,
leukocytes were given one additional wash with buffer EL (Qiagen)
to ensure removal of erythrocytes and any potential RT-PCR
inhibitors. Samples were all treated on-column with the RNase-
free DNase kit (Qiagen).
RNA concentration was measured in a Qubit fluorometer
(Invitrogen). 1 mg of isolated total RNA was reversed transcribed
with oligo-dT primers using the Taqman Reverse Transcription
Reagents kit (Applied Biosystems N808-0234) in a final volume of
100 ml following the manufacturer’s instructions. Some volunteer
whole blood was also processed as described above for the Lung
Transplant Patients and no difference was found in CK5
expression in the circulation when blood was processed fresh or
frozen in TRIzol.
Conventional PCR
PCR for CK5 and GAPDH was performed on cDNA template
using intron-spanning primers. All primers are listed 59-39. Primers
used were hCK5spanf (CTTGTGGAGTGGGTGGCTAT),
hCK5spanR (CCACTTGGTGTCCAGAACCT) (CK5 GeneID:
3852), GAPDHf (GGAGTCAACGGGTATTTGGT) and
GAPDHr (GACAAGCTTCCCGTTCTCAG). Cycling condi-
tions were 95uC for 5 min, 40 cycles of 95uC for 30 sec, 56uC
for 30 sec, 72uC for 30 sec and followed by a 5 min extension step
at 72uC.
Taqman primer/probe design
Taqman primers and probe were designed using a web based
tool from Genscript (https://www.genscript.com/ssl-bin/app/
primer) with manual fine-tuning. The primer-probe set was
selected so that the forward primer (TTCTTTGATGCG-
GAGCTGT) was positioned over an exon-exon junction. The
reverse primer sequence is CATGGAGAGGACCACTGAGG.
The resulting primer pair amplifies a 66 bp fragment. The
Taqman probe is labeled at the 59 end with a fluorescent dye (6-
carboxy-fluorescein, FAM) and on the 39 end with a quencher (6-
carboxy-tetramethyl-rhodamine, TAMRA). Primers and probe
were synthesized by IDT (Coralville, IA). The sequence of the
probe is CCCAGATGCAGACGCATGTCTCTG. A Blast
search (NCBI, NIH) showed no significant homology with other
known genes in the database.
The housekeeping gene, glyceraldehyde 3-phosphate dehydro-
genase (GAPDH), was obtained as a pre-designed VIC labeled
qPCR assay from Applied Biosystems (4310884E) (Foster City,
CA) and used according to the manufacturer’s instructions.
CK5 qPCR assay optimization and validation
Optimal primer/probe concentrations were determined by first
varying primer concentrations against the maximum recommend-
ed concentration of probe (250 nM). Subsequently, the concen-
tration of probe was titrated. The concentration at which, for both
primers and probe, the DCt and DRn did not change with
increasing concentrations was selected.
Singleplex and multiplex qPCR was then performed to
determine the compatibility of the CK5 assay with the assay for
the internal control GAPDH. No competition between assays was
observed, thus permitting the use of multiplex qPCR.
To determine the sensitivity and reproducibility of the assay,
serial dilutions of cDNA template representing 5 log steps were
prepared and run in triplicate. There was very little variation
between the Ct triplicate measurements with the average standard
deviation being 0.12 and the maximum deviation being 0.6 for all
triplicate readings whose average delta Ct was within the range of
the assay detection limits (i.e. Ct,36).
Taqman qPCR conditions
Real-time amplification and detection was performed with the
ABI Step One Plus (Applied Biosystems) sequence detection
system. Each reaction included 250 nM probe, 600 nM forward
primer, 600 nM reverse primer, 7.5 ml Taqman Fast Universal
PCR master mix (Applied Biosystems), nuclease free water, and,
with the exception of the standard curve, 5 ml of cDNA
corresponding to 50 ng of total RNA. Cycling conditions used
were 20 sec at 95uC, and 40 cycles of 1 sec denaturation at 95uC
and 20 sec annealing at 60uC.
Quantification and statistics
The comparative Ct method for multiplex PCR was performed
as outlined in the ABI PRISM 7700 Sequence Detection System
User Bulletin #2 (available on the Applied Biosystems website:
http://www3.appliedbiosystems.com). Each sample was run in
triplicate and amplified for the gene of interest CK5 and the
housekeeping gene GAPDH. Samples that required more than 30
cycles to reach the threshold cycle (Ct) for GAPDH were discarded
as it possibly indicated poor cDNA quality. Otherwise, the
triplicate Ct values for each sample were averaged resulting in
mean Ct values for both CK5 and GAPDH. The CK5 Ct values
were then standardized to the housekeeping gene by taking the
difference: DCt=Ct[CK5]2Ct[GAPDH]. In order to compare
DCt values between cases and controls, we averaged the DCt
values among the control samples and used the avg(DCt in
controls) as a reference or calibrator DDCt=DCt[sam-
ple]2avg(DCt controls). The fold-change between each sample
and the reference sample was calculated as 22DDCt for negative
DDCt values (which indicated an increase in fold change) and
22DDCt for positive DDCt values (indicating a fold change
decrease)[13,14].
Statistical analyses were primarily performed on DCt distribu-
tions, as they were closer to Gaussian than the fold change
distributions, which were highly skewed. An exact Wilcoxon rank
sum test was used to compare DCt distributions between
transplant and control patients. Kendall rank correlation was
used to test for associations between DCt values and other
variables such as age and time. An exact Wilcoxon signed rank test
was used to test for change in DCt values within patients over time.
Mixed effects logistic regression models were used to study
relationships between infection, rejection, and DCt. Scatterplots
and box plots were helpful for visualizing the data and linear
regression tools such as Cook’s distance identified outliers.
Bonferroni correction for multiple testing was considered in
interpreting statistical significance. All analyses were performed
using R, a free statistical program available at http://cran.r-
project.org/.
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